Potentiation of 1,3-Bis(2-chloroethyl)-1-nitrosourea cytotoxicity in 9L rat brain tumor cells by methylglyoxal-bis(guanylhydrazone), an inhibitor of S-adenosyl-l-methionine decarboxylase

David T. Hung, Stina M. Oredsson, Anthony Pegg, Dennis F. Deen, Laurence J. Marton

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Methylglyoxal-bis(guanylhydrazone) (MGBG), a potent inhibitor of the spermidine and spermine biosynthetic enzyme S-adenosyl-l-methionine decarboxylase, enhanced the cytotoxicity of 1,3-bis-(2-chlorethyl)-1-nitrosourea in 9L rat brain tumor cells in vitro, as measured by a colony-forming efficiency assay, by an amount that was approximately the same as the potentiation caused by the ornithine decarboxylase inhibitor α-difluoromethylornithine. Dose enhancement ratios at 10, 1 and 0.1% survival levels were approximately 1.3 for both inhibitors. 9L cells that were treated for 48 hr with 40 μM MGBG had putrescine, spermidine and spermine levels that were 112, 41 and 21% respectively, of polyamine levels in control cells. MGBG treatment does not increase intracellular levels of decarboxylated S-adenosyl-l-methionine (AdoMet) as α-difluoromethylornithine treatment does. Elevated levels of decarboxylated AdoMet could modify intracellular methylation reactions and could affect the cytotoxicity of a chloroethylnitrosourea. Despite the fact that MGBG treatment caused a slight increase in intracellular levels of AdoMet, it is unlikely that this elevation will increase the amount of intracellular methylation. Thus it appears that effects caused by the decrease in polyamine levels are responsible for the potentiation of chloroethylnitrosourea cytotoxicity against 9L cells.

Original languageEnglish (US)
Pages (from-to)417-420
Number of pages4
JournalEuropean Journal of Cancer and Clinical Oncology
Volume20
Issue number3
DOIs
StatePublished - Jan 1 1984

Fingerprint

Mitoguazone
Carmustine
Brain Neoplasms
Methionine
Eflornithine
Spermidine
Spermine
Polyamines
Methylation
Putrescine
methionine decarboxylase
Enzymes

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

@article{a69f1a3ade0a4690ba1a0d60a40f6d70,
title = "Potentiation of 1,3-Bis(2-chloroethyl)-1-nitrosourea cytotoxicity in 9L rat brain tumor cells by methylglyoxal-bis(guanylhydrazone), an inhibitor of S-adenosyl-l-methionine decarboxylase",
abstract = "Methylglyoxal-bis(guanylhydrazone) (MGBG), a potent inhibitor of the spermidine and spermine biosynthetic enzyme S-adenosyl-l-methionine decarboxylase, enhanced the cytotoxicity of 1,3-bis-(2-chlorethyl)-1-nitrosourea in 9L rat brain tumor cells in vitro, as measured by a colony-forming efficiency assay, by an amount that was approximately the same as the potentiation caused by the ornithine decarboxylase inhibitor α-difluoromethylornithine. Dose enhancement ratios at 10, 1 and 0.1{\%} survival levels were approximately 1.3 for both inhibitors. 9L cells that were treated for 48 hr with 40 μM MGBG had putrescine, spermidine and spermine levels that were 112, 41 and 21{\%} respectively, of polyamine levels in control cells. MGBG treatment does not increase intracellular levels of decarboxylated S-adenosyl-l-methionine (AdoMet) as α-difluoromethylornithine treatment does. Elevated levels of decarboxylated AdoMet could modify intracellular methylation reactions and could affect the cytotoxicity of a chloroethylnitrosourea. Despite the fact that MGBG treatment caused a slight increase in intracellular levels of AdoMet, it is unlikely that this elevation will increase the amount of intracellular methylation. Thus it appears that effects caused by the decrease in polyamine levels are responsible for the potentiation of chloroethylnitrosourea cytotoxicity against 9L cells.",
author = "Hung, {David T.} and Oredsson, {Stina M.} and Anthony Pegg and Deen, {Dennis F.} and Marton, {Laurence J.}",
year = "1984",
month = "1",
day = "1",
doi = "10.1016/0277-5379(84)90090-7",
language = "English (US)",
volume = "20",
pages = "417--420",
journal = "European Journal of Cancer and Clinical Oncology",
issn = "0277-5379",
publisher = "Pergamon Press",
number = "3",

}

Potentiation of 1,3-Bis(2-chloroethyl)-1-nitrosourea cytotoxicity in 9L rat brain tumor cells by methylglyoxal-bis(guanylhydrazone), an inhibitor of S-adenosyl-l-methionine decarboxylase. / Hung, David T.; Oredsson, Stina M.; Pegg, Anthony; Deen, Dennis F.; Marton, Laurence J.

In: European Journal of Cancer and Clinical Oncology, Vol. 20, No. 3, 01.01.1984, p. 417-420.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Potentiation of 1,3-Bis(2-chloroethyl)-1-nitrosourea cytotoxicity in 9L rat brain tumor cells by methylglyoxal-bis(guanylhydrazone), an inhibitor of S-adenosyl-l-methionine decarboxylase

AU - Hung, David T.

AU - Oredsson, Stina M.

AU - Pegg, Anthony

AU - Deen, Dennis F.

AU - Marton, Laurence J.

PY - 1984/1/1

Y1 - 1984/1/1

N2 - Methylglyoxal-bis(guanylhydrazone) (MGBG), a potent inhibitor of the spermidine and spermine biosynthetic enzyme S-adenosyl-l-methionine decarboxylase, enhanced the cytotoxicity of 1,3-bis-(2-chlorethyl)-1-nitrosourea in 9L rat brain tumor cells in vitro, as measured by a colony-forming efficiency assay, by an amount that was approximately the same as the potentiation caused by the ornithine decarboxylase inhibitor α-difluoromethylornithine. Dose enhancement ratios at 10, 1 and 0.1% survival levels were approximately 1.3 for both inhibitors. 9L cells that were treated for 48 hr with 40 μM MGBG had putrescine, spermidine and spermine levels that were 112, 41 and 21% respectively, of polyamine levels in control cells. MGBG treatment does not increase intracellular levels of decarboxylated S-adenosyl-l-methionine (AdoMet) as α-difluoromethylornithine treatment does. Elevated levels of decarboxylated AdoMet could modify intracellular methylation reactions and could affect the cytotoxicity of a chloroethylnitrosourea. Despite the fact that MGBG treatment caused a slight increase in intracellular levels of AdoMet, it is unlikely that this elevation will increase the amount of intracellular methylation. Thus it appears that effects caused by the decrease in polyamine levels are responsible for the potentiation of chloroethylnitrosourea cytotoxicity against 9L cells.

AB - Methylglyoxal-bis(guanylhydrazone) (MGBG), a potent inhibitor of the spermidine and spermine biosynthetic enzyme S-adenosyl-l-methionine decarboxylase, enhanced the cytotoxicity of 1,3-bis-(2-chlorethyl)-1-nitrosourea in 9L rat brain tumor cells in vitro, as measured by a colony-forming efficiency assay, by an amount that was approximately the same as the potentiation caused by the ornithine decarboxylase inhibitor α-difluoromethylornithine. Dose enhancement ratios at 10, 1 and 0.1% survival levels were approximately 1.3 for both inhibitors. 9L cells that were treated for 48 hr with 40 μM MGBG had putrescine, spermidine and spermine levels that were 112, 41 and 21% respectively, of polyamine levels in control cells. MGBG treatment does not increase intracellular levels of decarboxylated S-adenosyl-l-methionine (AdoMet) as α-difluoromethylornithine treatment does. Elevated levels of decarboxylated AdoMet could modify intracellular methylation reactions and could affect the cytotoxicity of a chloroethylnitrosourea. Despite the fact that MGBG treatment caused a slight increase in intracellular levels of AdoMet, it is unlikely that this elevation will increase the amount of intracellular methylation. Thus it appears that effects caused by the decrease in polyamine levels are responsible for the potentiation of chloroethylnitrosourea cytotoxicity against 9L cells.

UR - http://www.scopus.com/inward/record.url?scp=0021322545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021322545&partnerID=8YFLogxK

U2 - 10.1016/0277-5379(84)90090-7

DO - 10.1016/0277-5379(84)90090-7

M3 - Article

VL - 20

SP - 417

EP - 420

JO - European Journal of Cancer and Clinical Oncology

JF - European Journal of Cancer and Clinical Oncology

SN - 0277-5379

IS - 3

ER -